Clinical trials
Recurrence trials in Italy with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2023 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AGO Study Group | 1 |
| Azienda Ospedaliera San Giovanni Battista | 1 |
| CNAO National Center of Oncological Hadrontherapy | 1 |
| Catholic University of the Sacred Heart | 1 |
| Fondazione del Piemonte per l'Oncologia | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Paolo Puppo | 1 |
| S. Andrea Hospital | 1 |
| University Of Perugia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 13 |
| Ovarian Neoplasms | 3 |
| Leukemia, Myeloid, Acute | 2 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Urinary Bladder Neoplasms | 2 |
| Anastomotic Leak | 1 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.